Why is Saroja Pharma In falling/rising?

As of 08-Sep, Saroja Pharma Industries India Ltd is experiencing a decline in its stock price, currently at 49.25, which represents a decrease of 2.5 or 4.83%. The stock has underperformed its sector by 4.7% today, and there has been a notable drop in investor participation, with delivery volume falling by 44.44% compared to the 5-day average. Over the past week, the stock has shown a positive return of 2.50%, but it has significantly underperformed on a year-to-date basis with a decline of 17.92%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, while Saroja Pharma's short-term performance has been positive over the past week, it still lags behind the benchmark Sensex, which has gained 0.60% in the same period. Additionally, the stock's year-to-date performance contrasts sharply with the Sensex's gain of 4.77%, indicating a significant underperformance relative to the broader market. This disparity suggests that while there may be some short-term gains, the overall trend for Saroja Pharma remains negative when viewed against both its historical performance and the market as a whole.